Screener
BioMarin Pharmaceuticals BMRN Net debt
Discontinued — last reported Q2 '26
Net debt at other companies
Other financials
Where this comes from
Calculated from BioMarin Pharmaceuticals’s reported figures.
The source filing: BioMarin Pharmaceuticals’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:14 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001048477-26-000016
FAQ
- What is BioMarin Pharmaceuticals's net debt?
- BioMarin Pharmaceuticals (BMRN) reported net debt of $3.31B in Q2 2026.
- How has BioMarin Pharmaceuticals's net debt changed year-over-year?
- BioMarin Pharmaceuticals's net debt increased by 639.6% year-over-year, from -$613.82M to $3.31B.
- What is the long-term trend for BioMarin Pharmaceuticals's net debt?
- Over 5 years (2020 to 2025), BioMarin Pharmaceuticals's net debt has grown at a 2.4% compound annual growth rate (CAGR), from -$592.92M to -$668.81M.
- What does net debt mean?
- Total debt minus cash and equivalents at the quarter end. The debt that would remain if the company used all its cash to pay down borrowings.
Ask your AI about BioMarin Pharmaceuticals's net debt.
Connect your AI assistant and see it in context, right in your chat.
Connect your AI
Claude